Trabeculectomy Procedure
Description, Latest Information and Doctors

Save information for later
Sign Up

Learn About Trabeculectomy

Who are the top Trabeculectomy Local Doctors?
Davinder S. Grover
Elite in Trabeculectomy
Elite in Trabeculectomy

Glaucoma Associates Of Texas - Dallas

10740 N Central Expy, Ste 300, 
Dallas, TX 
Languages Spoken:
English

Davinder Grover is an Ophthalmologist in Dallas, Texas. Dr. Grover is rated as an Elite provider by MediFind in Trabeculectomy. His top areas of expertise are Glaucoma, Pigment-Dispersion Syndrome, Ocular Hypertension (OHT), Trabeculectomy, and Iridectomy.

Oluwatosin U. Smith
Elite in Trabeculectomy
Elite in Trabeculectomy

Glaucoma Associates Of Texas - Dallas

10740 N Central Expy, Ste 300, 
Dallas, TX 
Languages Spoken:
English, Yoruba

Oluwatosin Smith is an Ophthalmologist in Dallas, Texas. Dr. Smith is rated as an Elite provider by MediFind in Trabeculectomy. Her top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Iridectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Harry A. Quigley
Elite in Trabeculectomy
Ophthalmology
Elite in Trabeculectomy
Ophthalmology

The Johns Hopkins Hospital

Baltimore, MD 
Languages Spoken:
English

Dr. Harry A. Quigley is the A. Edward Maumenee Professor of Ophthalmology and developed the Glaucoma Division at the Johns Hopkins Wilmer Eye Institute. He was a founding member of the American Glaucoma Society, serving for 8 years as its Secretary and was elected to 5 year terms as chief executive officer of the Association for Research in Vision and Ophthalmology (ARVO) and editor-in-chief of Investigative Ophthalmology and Visual Science. He has published over 350 peer-reviewed articles, and his reports are the most cited in the ophthalmic literature over the last 30 years (Archives of Ophthalmology, 2007). His research has improved the early diagnosis of glaucoma and has developed instruments and techniques to identify glaucoma damage better. He has participated in pioneering studies of the epidemiology, morbidity and progression rate of glaucoma and other eye disease in American, African, Asian and Hispanic populations, serving as a consultant to the World Health Organization. In the laboratory, he has demonstrated successful gene therapy to protect retinal ganglion cells from experimental glaucoma and developed glaucoma models in monkeys, rats and mice. Dr. Quigley is rated as an Elite provider by MediFind in Trabeculectomy. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Iridectomy.

What are the latest Trabeculectomy Clinical Trials?
Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Medication Burden in Medically Controlled Patients With Ocular Hypertension or Primary Open Angle Glaucoma

Summary: This is a prospective, single arm, open label study conducted at a single site to evaluate the efficacy of Direct Selective Laser Trabeculoplasty (DSLT) in reducing medication burden in patients with medically controlled ocular hypertension or primary open angle glaucoma. The study will assess the primary endpoint of reduction in medication count at 6 months compared to baseline. Secondary endpoin...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Pilot Study of the OMNI 3.1 Surgical System in Subjects With Primary Open-Angle Glaucoma

Summary: To gain early evidence of safety and assess the effectiveness of the intraocular pressure (IOP)-lowering effectiveness of the OMNI 3.0 Surgical System in primary open-angel glaucoma (POAG).